Scott Kuwada to Angiogenesis Inhibitors
This is a "connection" page, showing publications Scott Kuwada has written about Angiogenesis Inhibitors.
Connection Strength
0.281
-
Kuwada SK. Drug evaluation: Volociximab, an angiogenesis-inhibiting chimeric monoclonal antibody. Curr Opin Mol Ther. 2007 Feb; 9(1):92-8.
Score: 0.281
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.